Archive
145 evidence-based reports across medicine, nutrition, mental well-being, chronic conditions, and healthcare technology.
Showing 12 of 145 stories · page 3 of 13
Late August 2026 brought a wave of FDA recalls affecting Clear Eyes eye drops, alfalfa sprouts linked to E. coli and salmonella, a dabigatran impurity pull, and a TikTok-famous collagen. Here is what to check, what to do, and how to spot a recall before the next dose.
Chronic dry eye disease is two to three times more common in women than men, and the gap widens sharply during perimenopause. The cause is hormonal, the consequences are real, and the treatments are better than the over-the-counter drops most women try first.
Hot flashes and brain fog are real, frequent, and disruptive in the workplace. Under the ADA and EEOC guidance, severe menopausal symptoms can qualify as a disability requiring reasonable accommodation. Here is what to ask for, how to document, and what protections the law actually offers.
A 2026 Journal of Sexual Medicine study found that many women treated repeatedly for recurrent UTIs had no infection at all. The real cause was hormonally driven inflammation and pelvic floor dysfunction, both of which respond to non-antibiotic treatment.
Walmart agreed to pay $50 million to settle Justice Department claims that its pharmacies filled suspicious opioid prescriptions for years. The case is the first major federal action against a retail pharmacy chain for its role in the opioid epidemic, and it changes what patients should expect at the counter.
CGRP-targeted migraine preventives changed treatment for people who failed older pills. We explain how they work, who they help, the injection-vs-pill choice, and what the 2026 evidence shows about effectiveness and tolerability.
The 2026 ACS guideline added a blood test and a new RNA stool test to colon cancer screening. We explain how Shield, Cologuard, FIT, and colonoscopy compare — and where the blood test falls short.
Most inhaler failures in COPD are not the drug — they are the technique. We explain common errors, why switching devices confuses patients, and how to get the medicine where it belongs.
Direct oral anticoagulants (DOACs) replaced warfarin for many people with atrial fibrillation. We explain why DOACs need less monitoring, how they compare on stroke and bleeding, and who still needs warfarin.
Atopic dermatitis is more than dry skin, and the fear of topical steroids keeps many from relief. We explain dupilumab and other biologics, safe steroid use, and what 2026 guidance says.
Irritable bowel syndrome is a real gut-brain disorder, not imagined stress. We explain the low-FODMAP diet, rifaximin and linaclotide, and which tests rule out something else.
Long COVID affects millions, but proven treatments are scarce. We explain the 2026 evidence on pacing, the failed Paxlovid and metformin treatment trials, and prevention that actually works.
